Skip to main content

Grafa News and Videos — Page 1397

Latest

Grafa

Henlius and Organon secure EC approval for POHERDY, Europe’s first Pertuzumab biosimilar

Shanghai Henlius Biotech and Organon (NYSE:OGN) announced on Wednesday, April 29, 2026, that the European Commission (EC) has granted marketing authorization for POHERDY (pertuzumab), making it the first and only approved biosimilar to the reference product PERJETA in Europe.

Read more: Henlius and Organon secure EC approval for POHERDY, Europe’s first Pertuzumab biosimilar

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift